Please assess the completion status of the following clinical trial:

Trial Title: The Biology of Resilience

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* age 22-65, BMI \< 30, healthy, English-speaking, 9th grade reading level.~Exclusion Criteria:~* any known medical condition (including mental disorders) or on any type of medication~* high levels of social anxiety~* smokers~* high rates of alcohol or drug use~* pregnant or suspected pregnant~* breastfeeding~* blood pressures \> 140/90 mm Hg~* subject does not have a close friend available to participate in the study with him/her

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Oxytocin (Type: EXPERIMENTAL): One primary experimental manipulation is the receipt of intranasal oxytocin vs placebo spray prior to participation in a psychosocial stress protocol
- Placebo (Type: PLACEBO_COMPARATOR): The comparison condition for receipt of oxytocin is receipt of a saline intranasal spray
- Social Support (Type: EXPERIMENTAL): Participants bring a friend to the laboratory who sits with them while they engage in the stress protocol tasks
- No Social Support (Type: PLACEBO_COMPARATOR): Individuals in this condition do not have a friend present while they are engaging in the laboratory protocol.
- Female Gender (Type: OTHER): Effects of oxytocin and social support are examined among women versus men
- Male Gender (Type: OTHER): Consider effects of oxytocin and social support in men versus women

Based on this trial design, predict the completion outcome and termination type (if applicable).